<html>
<head>
  <title>SARS-CoV-2 Membrane protein (M) gene E166Q literature reference collection</title>
  <link rel="stylesheet" href="constellations.css">
</head>
<body>
<h1><a href="front.html">SARS-CoV-2</a> <a href="M.html">Membrane protein (M)</a> gene <span class="constellation">M:p.E166Q</span> literature reference collection</h1>
<div class="effect_section"><h2 id="pharmaceutical_effectiveness">Pharmaceutical effectiveness</h2>
<ul class="lit_list">
<li class="lit_item"><span class="lit_summary"> This mutation is candidate for resistance to the first FDA-authorized Mpro inhibitor, PF-07321332.<br/>It has WT-like function in both the FRET and growth screens, would lead to a predicted decrease in  inhibitor binding energy upon mutation of greater than 1 kcal/mol, and is a single nucleotide base change. <br/> (<a href="https://doi.org/10.1101/2022.01.26.477860" class="lit_link">Flynn et al. (2022)</a>)</span></li>
</ul></div>
<div class="acknowledgement">Automatically generated using text2ui script and data from <a href="https://github.com/nodrogluap/pokay">Pokay</a></div>
</body>
</html>
